JP2022546040A5 - - Google Patents
Info
- Publication number
- JP2022546040A5 JP2022546040A5 JP2022513127A JP2022513127A JP2022546040A5 JP 2022546040 A5 JP2022546040 A5 JP 2022546040A5 JP 2022513127 A JP2022513127 A JP 2022513127A JP 2022513127 A JP2022513127 A JP 2022513127A JP 2022546040 A5 JP2022546040 A5 JP 2022546040A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- dsrna
- chain contains
- optionally
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024180454A JP7892042B2 (ja) | 2019-08-27 | 2024-10-16 | Pcsk9を阻害するための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19306036 | 2019-08-27 | ||
| EP19306036.5 | 2019-08-27 | ||
| PCT/EP2020/073961 WO2021037972A1 (en) | 2019-08-27 | 2020-08-27 | Compositions and methods for inhibiting pcsk9 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024180454A Division JP7892042B2 (ja) | 2019-08-27 | 2024-10-16 | Pcsk9を阻害するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546040A JP2022546040A (ja) | 2022-11-02 |
| JP2022546040A5 true JP2022546040A5 (cg-RX-API-DMAC7.html) | 2023-09-04 |
Family
ID=67956661
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513127A Pending JP2022546040A (ja) | 2019-08-27 | 2020-08-27 | Pcsk9を阻害するための組成物および方法 |
| JP2024180454A Active JP7892042B2 (ja) | 2019-08-27 | 2024-10-16 | Pcsk9を阻害するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024180454A Active JP7892042B2 (ja) | 2019-08-27 | 2024-10-16 | Pcsk9を阻害するための組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220290156A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4022061A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022546040A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115176011B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021037972A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11597744B2 (en) | 2017-06-30 | 2023-03-07 | Sirius Therapeutics, Inc. | Chiral phosphoramidite auxiliaries and methods of their use |
| CN113166760A (zh) | 2018-11-23 | 2021-07-23 | 赛诺菲 | 用于抑制angptl8的新型rna组合物和方法 |
| US20220372063A1 (en) * | 2019-09-05 | 2022-11-24 | Sanofi | Oligonucleotides containing nucleotide analogs |
| CN119451971A (zh) * | 2022-06-27 | 2025-02-14 | 大睿生物医药科技(上海)有限公司 | 具有增强的稳定性的核苷酸替代物 |
| JP2025532985A (ja) | 2022-09-30 | 2025-10-03 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | 修飾二本鎖rna剤 |
| AU2024265748A1 (en) * | 2023-05-04 | 2025-10-23 | Argonaute RNA Limited | Dual silencing |
| JP2026522625A (ja) * | 2023-06-21 | 2026-07-08 | セーンジーン バイオ ユーエスエー インコーポレイティド | プロタンパク質転換酵素サブチリシン・ケキシン9型(pcsk9)を標的とする二本鎖rna、およびその使用方法 |
| AU2024360473A1 (en) * | 2023-11-06 | 2026-06-04 | Hangzhou Tianlong Pharmaceutical Co., Ltd. | Modification template for improving inhibitory effect of double-stranded oligonucleotide on target gene, combination thereof and use thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5665710A (en) | 1990-04-30 | 1997-09-09 | Georgetown University | Method of making liposomal oligodeoxynucleotide compositions |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| JPH07509133A (ja) | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6054299A (en) | 1994-04-29 | 2000-04-25 | Conrad; Charles A. | Stem-loop cloning vector and method |
| US5981501A (en) | 1995-06-07 | 1999-11-09 | Inex Pharmaceuticals Corp. | Methods for encapsulating plasmids in lipid bilayers |
| JP4335310B2 (ja) | 1995-06-07 | 2009-09-30 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用 |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| DK1068311T3 (da) | 1998-04-08 | 2011-08-08 | Commw Scient Ind Res Org | Fremgangsmåder og midler til opnåelse af modificerede fænotyper |
| AR020078A1 (es) | 1998-05-26 | 2002-04-10 | Syngenta Participations Ag | Metodo para alterar la expresion de un gen objetivo en una celula de planta |
| ATE237312T1 (de) | 1998-07-20 | 2003-05-15 | Protiva Biotherapeutics Inc | In liposomen verkapselte nukleinsäurekomplexe |
| BR9914772A (pt) | 1998-10-09 | 2001-12-11 | Ingene Inc | Conjunto de elementos genéticos, vetor, célulahospedeira, conjunto para a produção de umasequência de ácido nucléico, método para aprodução in vivo ou in vitro de uma sequência deácido nucléico, transcrição de cdna, molécula deácido nucléico inibidor, transcrição de mrna,molécula heteroduplex e composiçãofarmacêutica |
| AU6298899A (en) | 1998-10-09 | 2000-05-01 | Ingene, Inc. | Production of ssdna (in vivo) |
| DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| CN100365122C (zh) * | 2005-12-30 | 2008-01-30 | 中国疾病预防控制中心病毒病预防控制所 | 针对乙型流感病毒多聚酶基因的siRNA序列及其应用 |
| US7605251B2 (en) * | 2006-05-11 | 2009-10-20 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of the PCSK9 gene |
| CA2658183A1 (en) * | 2006-07-17 | 2008-01-24 | Sirna Therapeutics Inc. | Rna interference mediated inhibition of proprotein convertase subtilisin kexin 9 (pcsk9) gene expression using short interfering nucleic acid (sina) |
| EP2229186A2 (en) | 2007-12-04 | 2010-09-22 | Alnylam Pharmaceuticals Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| WO2010093788A2 (en) | 2009-02-11 | 2010-08-19 | Dicerna Pharmaceuticals, Inc. | Multiplex dicer substrate rna interference molecules having joining sequences |
| NZ597504A (en) * | 2009-06-15 | 2013-10-25 | Alnylam Pharmaceuticals Inc | Lipid formulated dsrna targeting the pcsk9 gene |
| WO2013154766A1 (en) * | 2012-04-13 | 2013-10-17 | New York University | Microrna control of ldl receptor pathway |
| BR112015013105B1 (pt) * | 2012-12-05 | 2022-02-08 | Alnylam Pharmaceuticals, Inc | Agente de rnai de fita dupla capaz de inibir a expressão de pcsk9, seus usos, composição farmacêutica e método de inibição da expressão de pcsk9 em uma célula in vitro |
| PL2992098T3 (pl) | 2013-05-01 | 2019-09-30 | Ionis Pharmaceuticals, Inc. | Kompozycje i sposoby modulowania ekspresji hbv i ttr |
| CN112105625B (zh) * | 2018-03-07 | 2024-12-31 | 赛诺菲 | 核苷酸前体、核苷酸类似物以及含其的寡聚化合物 |
| CN112368381A (zh) * | 2018-04-18 | 2021-02-12 | 迪克纳制药公司 | 用于治疗高胆固醇血症和相关病况的pcsk9靶向寡核苷酸 |
-
2020
- 2020-08-27 CN CN202080073296.3A patent/CN115176011B/zh active Active
- 2020-08-27 US US17/638,339 patent/US20220290156A1/en active Pending
- 2020-08-27 WO PCT/EP2020/073961 patent/WO2021037972A1/en not_active Ceased
- 2020-08-27 EP EP20761581.6A patent/EP4022061A1/en active Pending
- 2020-08-27 JP JP2022513127A patent/JP2022546040A/ja active Pending
-
2024
- 2024-10-16 JP JP2024180454A patent/JP7892042B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018363840B2 (en) | Nucleic acids for inhibiting expression of LPA in a cell | |
| JP7249080B2 (ja) | 可逆的に修飾されたオリゴヌクレオチドを含む組成物及びその使用 | |
| ES2924806T3 (es) | Análogos de 4'-fosfato y oligonucleótidos que comprenden el mismo | |
| JP2022513111A5 (cg-RX-API-DMAC7.html) | ||
| DK2431466T3 (en) | Single-stranded nucleic acid molecule for the control of gene expression | |
| EP2635681B1 (en) | Base modified oligonucleotides | |
| CN110573619B (zh) | 抑制tmprss6基因表达的核酸产品和其用途 | |
| JP2022547888A5 (cg-RX-API-DMAC7.html) | ||
| EP2013344B1 (en) | Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease | |
| CN119842706A (zh) | 用于抑制细胞中lpa的表达的核酸 | |
| EP2857513A1 (en) | Single-stranded nucleic acid molecule for regulating expression of gene having delivering function | |
| TW201615835A (zh) | 具有含氮脂環骨架之單股核酸分子(二) | |
| CN113164768A (zh) | 用于抑制tmprss6表达的核酸和铁螯合剂 | |
| WO2025016446A1 (en) | Lipids and lipid nanoparticles | |
| JP6974872B2 (ja) | ヘテロ二本鎖型antimiR | |
| CN119552122B (zh) | 5'-磷酸酯修饰核苷及其制备方法与应用 | |
| HK40005478B (en) | Compositions comprising reversibly modified oligonucleotides and uses thereof | |
| HK40005478A (en) | Compositions comprising reversibly modified oligonucleotides and uses thereof | |
| HK40031790A (en) | Nucleic acids for inhibiting expression of lpa in a cell |